Wednesday, May 29, 2024
name of Prensa Latina
Bandera inglesa
English Edition
Close this search box.
name of Prensa Latina



Mexico, Jun 20 (Prensa Latina) Mexican media on Sunday highlighted the success of Cuba's Covid-19 vaccine candidate Soberana 02, developed by the Finlay Vaccines Institute (IFV) in Havana, with an efficacy higher than what the World Health Organization (WHO) establishes.
Havana, Jun 7 (Prensa Latina) Members of the control group (placebo) of the Phase III clinical trial of Soberana 02 Covid-19 vaccine candidate receive immunization as of Monday, as part of that study starting in March in eight Havana municipalities.